HOME   Cart(0)   Quotation   About-Us Tax PDFs Standard-List Powered by Google www.ChineseStandard.net Database: 189759 (8 Sep 2024)

YY/T 1192-2011 English PDF

YY/T 1192-2011 (YY/T1192-2011, YYT 1192-2011, YYT1192-2011)
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusPDF
YY/T 1192-2011English150 Add to Cart 0--9 seconds. Auto-delivery Human chorionic gonadotropin (HCG) quantitative detection reagent (kit) (Chemiluminescent immunoassay) Valid YY/T 1192-2011
Standards related to: YY/T 1192-2011

BASIC DATA
Standard ID YY/T 1192-2011 (YY/T1192-2011)
Description (Translated English) Human chorionic gonadotropin (HCG) quantitative detection reagent (kit) (Chemiluminescent immunoassay)
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C44
Classification of International Standard 11.100
Word Count Estimation 9,958
Date of Issue 2011-12-31
Date of Implementation 2013-06-01
Quoted Standard GB/T 21415-2008
Drafting Organization Beijing Medical Device Testing
Administrative Organization National Standardization Technical Committee of Medical clinical testing laboratories and in vitro diagnostic systems
Regulation (derived from) State Food and Drug Administration Notice 2011 No. 106; industry standard filing Notice 2013 No. 6 (No. 162 overall)
Proposing organization State Food and Drug Administration
Issuing agency(ies) China Food and Drug Administration
Summary This standard specifies the shock cord human chorionic gonadotropin (HCG) quantitative assay (box) (chemiluminescent immunoassay) classification, requirements, test methods, marking, labeling, instructions, packaging, transportation and storage. This standard applies to the principle of chemiluminescence immunoassay for the quantitative detection of human blood or other body fluids matrix components of human chorionic gonadotropin shock cord (HCG) reagent (box) [The following tube called "HCG reagent (box)"]. Including microplates, tubes, magnetic particles, beads and plastic beads, etc. as the carrier of enzymatic and non-enzymatic chemiluminescence immunoassay reagent (box). This standard does not apply to: a) intended for human chorionic gonadotropin sold separately calibrators and control materials of human chorionic gonadotropin, b) to chemiluminescent immunoassay for the principle of bio-chips.

YY/T 1192-2011  YY ICS 11.100 C 44 INDUSTRY STANDARD OF THE PEOPLE’S REPUBLIC OF CHINA Human chorionic gonadotropin (HCG) quantitative detection reagent (kit) (chemiluminescent immunoassay) ISSUED ON. DECEMBER 31, 2011 IMPLEMENTED ON. JUNE 1, 2013 Issued by. State Food and Drug Administration Table of Contents Foreword ... 3  1  Scope ... 4  2  Normative references ... 4  3  Classification ... 4  4  Technical requirements ... 5  5  Test methods ... 6  6  Marks, labels and instructions ... 9  7  Packaging, transportation and storage ... 11  Bibliography ... 12  Foreword  This standard was drafted in accordance with the rules specified in GB/T 1.1-2009. Please note that some contents in this document may involve patents. The issuing organization of this document does not bear the responsibility to identify these patents. This standard was proposed by the China Food and Drug Administration. This standard shall be centralized by the China Clinical Laboratory Testing and In Vitro Diagnostic Test System of Standardization Administration of China (SAC/TC 136). Drafting organization of this standard. Beijing Institute of Medical Device Testing, Beijing Yuande Medical Engineering Co., Ltd., Beijing Chemclin Biotech Co., Ltd., Roche Diagnostic Products (Shanghai) Co., Ltd., and Zhengzhou Autobio Lv Ke Bioengineering Co., Ltd. The main drafters of this standard. Wang Ruixia, Tang Lei, Cheng Yinghao, Cai Xiaorong, and Li Xiaoxia. Human chorionic gonadotropin (HCG) quantitative detection reagent (kit) (chemiluminescent immunoassay) 1  Scope  This standard specifies the classification, requirements, test method, marks, labels, instructions, packaging, transportation and storage etc. of the human chorionic gonadotropin quantitative detection reagent (kit) (chemiluminescent immunoassay). This standard is applicable to the quantitative detection of human chorionic gonadotropin (HCG) reagent (kit) [hereinafter referred as “HCG reagent (kit)”] of the human blood matrix or other body fluid components, based on the principle of chemiluminescent immunoassay. It includes the enzymatic and non-enzymatic chemiluminescent immunoassay detection reagent (kit) in the carrier of microplates, pipes, magnetic particles, microbeads and plastic beads. This standard does not apply to. a) The calibrators and quality-control materials of human chorionic gonadotropin that are intended for separate sale; b) The biochip that uses chemiluminescent immunoassayas the principle. 2  Normative references  The articles contained in the following documents have become part of this document when they are quoted herein. For the dated documents so quoted, all the modifications (Including all corrections) or revisions made thereafter shall be applicable to this document. GB/T 21415-2008 In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials 3  Classification  HCG reagent (kit) can be divided into enzymatic and non-enzymatic chemiluminescent immunoassay reagents (kits) according to different principle of chemiluminescence. According to different solid-phase carriers, it can be divided into the chemiluminescent a) Product names and packaging specifications; b) Name, address, contact information of manufacturers or after-sales service organization; c) Medical device registration certificate number; d) Product standard number; e) Product batch number; f) Expiration date; g) Storage conditions. 6.2 Marks and labels of each component package of reagent (kit) It shall contain at least the following contents. a) Product name and packaging specifications; b) Name or trademarks of the manufacturers; c) Product batch number; d) Expiration date; e) Storage conditions. 6.3 Instructions of reagent (kit) It shall contain at least the following contents. a) Product name; b) Packaging specifications; c) Intended use; d) Detection principle; e) Main compositions; f) Storage conditions and expiration date; g) Applicable instrument; h) Sample requirement; i) Detection method; j) Reference value (Reference range); k) Explanation of the detection result; l) The limitations of detection methods; m) Product performance index. n) Instructions for analytical interference (hemolysis, lipemia, jaundice, etc.); o) Instructions for specificity analysis (cross-reactants); p) Precautions; q) References; r) Name, address, contact information of manufacturers or after-sales service organization; s) License number of medical device manufacturing enterprise (limited to domestic enterprises); t) Medical device registration certificate number; u) Product standard number; v) Approval and modified date of instructions. 7  Packaging, transportation and storage  7.1 Package Reagent (kit) shall be packaged according to the requirements of the manufacturing enterprise. 7.2 Transportation Reagent (kit) shall be transported according to the requirements of the manufacturing enterprise. 7.3 Storage Reagent (kit) shall be stored under the conditions specified by the manufacturing enterprise. Bibliography  1. YY/T 0316-2008 Medical devices — Application of risk management to medical devices (ISO 14971. 2007, IDT) 2. YY/T 0466.1-2009 Devices — Symbols to be used with medical device labels, labelling and information to be supplied — Part 1.General requirements (ISO 15223.1-2009, IDT) 3. GB/T 191-2008 Packaging - Pictorial marking for handling of goods 4. GB/T 9969-2008 General principles for preparation of instructions for use of industrial products ...